Novel approaches to tumor detection and therapy using a combination of monoclonal antibody and cytokine

Anticancer Research

Volumn 16, Issue 4 B, 1996, Pages 2129-2133

  Greiner, John W ^a   Guadagni, Fiorella ^b   Roselli, Mario ^c   Nieroda, Carol A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

detecting probe; interferon; Immunodiagnosis; Radioimmunotherapy

Indexed keywords

ALPHA INTERFERON; CANCER ANTIBODY; GAMMA INTERFERON; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ARTICLE; CANCER IMMUNOTHERAPY; PRIORITY JOURNAL; SERODIAGNOSIS; TUMOR; TUMOR DIAGNOSIS; TUMOR DIFFERENTIATION;

ANTIBODIES, MONOCLONAL; HUMANS; INTERFERON TYPE II; NEOPLASMS; RADIOIMMUNODETECTION; RADIOIMMUNOTHERAPY; TUMOR MARKERS, BIOLOGICAL;

EID: 0029795732     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Rosa FM, Fellous M: Regulation of HLA-DR gene by IFN-γ. Transcriptional and post-transcriptional control. J Immunol 140: 1660-1664, 1988.
2. Attallah AM, Needy CF, Noguchi PD, Elisherg BL: Enhancement of carcinoembryonic antigen expression by interferon. Int J Cancer 24: 49-52, 1979.
3. Guadagni F, Witt PL, Robbins PF, Schlom J, Greiner JW: Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-γ. Cancer Res 50: 6248-6255, 1990.
4. Hauck W, Stanners CP: Control of carcinoembryonic antigen gene family expression in a differentiating colon carcinoma cell line, Caco2. Cancer Res 51: 3526-3533, 1991.
5. Greiner JW, Guadagni F, Horan Hand P, Pestka S, Noguchi P, Fisher PB, Schlom J: Augmentation of tumor antigen expression by recombinant human interferons: Enhanced targeting of monoclonal antibodies to carcinomas. In: Goldenberg DM, McGuire WL, eds. Cancer imaging with radiolabeled antibodies. Boston: Martinus Nijhoff, 1990, pp. 413-432.
6. Kantor J, Tran R, Greiner JW, Pestka S, Fisher PB, Shively JE, Schlom J: Modulation of carcinoembryonic antigen messenger RNA levels in human colon carcinoma cells by recombinant human γ-interferon. Cancer Res 49: 2651-26S5, 1989.
7. Schlom J: New approaches to improved antibody targeting. Antibody Immunoconj Radiopharm 4: 819-828, 1991.
8. 111In-CYT-103). Antibody Immunoconj Radiopharm 2: 257-269, 1989.
9. Arnold MW, Schneebaum S, Berens A, Petty L, Mojzisik C, Hinkle G, Martin Jr EW: Intraoperative detection of colorectal cancer with radioimmunoguided surgery and CC49, a second-generation monoclonal antibody. Ann Surg 216: 11-16, 1992.
10. 131I-CC49) when given in combination with γ-interferon. Cancer Res 53: 600-608, 1993.
11. Nieroda C, Milenic DE, Carrasquillo JA, Schlom J, Greiner JW: Improved tumor radioimmunodetection using a single-chain Fv and interferon-γ: Potential clinical applications for radioimmunoguided surgery and γ-scanning. Cancer Res 55: 2858-2865, 1995.
12. Martin EW, Tuttle SE, Rousseau M, Mojzisik CD, O'Dwyer PJ, Hinkle GH, Miller EA, Goodwin RA, Oredipe OA, Barth RF, Olsen JO, Houchens D, Jewell SD, Bucci DM, Adams D, Steplewski Z, Hurston MO: Radioimmunoguided surgery: intraoperative use of monoclonal antibody 17-1A in colorectal cancer. Hybridoma 5: S97-S108, 1986.
13. Arnold MW, Schneebaum S, Berens A, Mojzisik C, Hinkle G, Martin Jr EW: Radioimmunoguided surgery challenges traditional decision making in primary colorectal cancer. Surgery 112: 624-630, 1992.
14. Oredipe OA, Barth RF, Tuttle SE, Adams DM, Sautins I, Bucci DM, Mojzisik CM, Hinkle GH, Jewell S, Steplewski Z, Thurston MO, Martin Jr EW: Limits of sensitivity for the radioimmunodetection of colon cancer by means of a hand held gamma probe. Nucl Med Biol 15: 595-603, 1988.
15. Hinkle GH, Mojzisik CM, Loesch JA, Hill TL, Thurston MO, Sampsel J, Olsen J, Martin Jr EW: The evolution of the radioimmunoguided surgery system: an innovative technique for the intraoperative detection of tumor. Antibody Immunoconj Radiopharm 4: 339-358, 1991.
16. Milenic DE, Yokota T, Filpula DR, Finkelman MAJ, Dodd SW. Wood JF, Whitlow M, Snoy P, Schlom J: Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res 51:6363-6371, 1991.
17. Yokota T, Milenic DE, Whitlow M, Wood JF, Hubert SL, Schlom J: Microauloradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms. Cancer Res 53: 3776-3708, 1993.
18. Arnold MW, Young DC, Hitchcock CL, Schneebaum S, Martin Jr EW: Radioimmunoguided surgery in primary colorectal carcinoma: An intraoperative prognostic tool and adjuvant to traditional staging. Amer J Surg 1995 (in press).
19. Epstein AL, Khawli LA, Hornick JL, Taylor CR: Identification of a monoclonal antibody, TV-1, directed against the basement membrane of tumor vessels, and its use to enhance the delivery of macromolecules to tumors after conjugation with interleukin-2. Cancer Res 55: 2673-2680, 1995.
20. 111In-labeled antimelanoma antibody 96.5 in melanoma patients. J Natl Cancer Inst 80: 160-165, 1988.
21. Greiner JW, Guadagni F, Goldstein D, Smalley RV, Borden EC, Simpson JF, Molinolo A, Schlom J: I.P. administration of interferongamma to carcinoma patients enhances expression of tumorassocialed glycoprotein-72 (TAG-72) and carcinoembryonic antigen (CEA) on malignant ascites cells. J Clin Oncol 10: 735-746, 1992.
22. Roselli M, Guadagni F, Buonomo O, Belardi A, Vittorini V, Mariani-Constantini R, Greiner JW, Casciani CU, Schlom J: Systemic administration of recombinant interferon-α in carcinoma patients upregulates the expression of the carcinoma associated antigens CEA and TAG-72. J Clin Oncol (submitted).
23. Murray JL, Macey DJ, Grant EJ, Rosenblum MG, Kasi LP, Zhang H-Z, Katz RL, Ricgcr PT, LeBherz D, Bhadkamkar V, Greiner JW, Schlom J, and Podoloff DA: Enhanced TAG-72 expression, and tumor uptake of radiolabeled monoclonal antibody CC49 in metastalic breast cancer patients following alpha interferon treatment. Cancer Res 1995 (in press).